2m 2m 2m 2m 2m 2m 2m
Opus Genetics (IRD)
NASDAQ
$3.72+$0.005 (+0.13%)
Price as of Aug 03, 2026 11:30 AM EDT- $306.3MMarket Cap
- 246.73%1-Year Change
- BiotechnologyIndustry
Opus Genetics (IRD)
$3.72+$0.005 (+0.13%)
IRD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.71 | ||
Change | -$0.13 (-3.39%) | ||
Open | $3.86 | ||
High | $3.86 | ||
Low | $3.62 | ||
Previous Close | $3.84 | ||
Volume | 969,741 | ||
30-Day Average Volume | 878,391 | ||
1-Week Change | 20.45% | ||
1-Month Change | -9.73% | ||
1-Year Change | 246.73% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.6M | ||
Total Assets | $66.8M | ||
Market Cap | $306.3M | ||
Enterprise Value | $247.6M | ||
Period: QTR TTM FY | |||
Revenue | $2.2M | ||
Net Income | -$65.5M | ||
Free Cash Flow | -$12.7M | ||
EBIT | -$65.4M | ||
EBITDA | -$65.4M | ||
Net Working Capital | $57.3M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 115 | ||
P/B | -7 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -24 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue